Format

Send to

Choose Destination
Vascul Pharmacol. 2005 Feb;42(3):119-23.

The use of angiotensin-converting enzyme inhibitors in patients undergoing coronary artery bypass graft surgery.

Author information

1
Department of Cardiothoracic Surgery, Boston University School of Medicine and Boston Medical Center, 88 East Newton Street, B402, Boston, MA 02118, USA. harold.lazar@bmc.org

Abstract

Angiotensin-converting enzyme inhibitors have been shown to prolong survival, decrease infarct size, and improve ventricular function in patients who have congestive heart failure, and in those who have sustained a myocardial infarction. This review will summarize the evidence to show that angiotensin-converting enzyme inhibitors can also benefit patients undergoing coronary artery bypass graft surgery by minimizing perioperative ischemia, and reducing long-term cardiovascular events.

PMID:
15792929
DOI:
10.1016/j.vph.2005.01.012
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center